Memorial Hermann Earns CMS Certification for Lung Transplant Program
Memorial Hermann-Texas Medical Center (TMC)
recently earned certification from the Centers for Medicare & Medicaid
Services (CMS) for lung transplants. The certification allows a wider range of
people in need to access safe, high-quality service through the Lung Transplant
Program at Memorial Hermann-TMC, per established CMS standards.
According to the United Network of Organ
Sharing (UNOS), only California and Pennsylvania
have more extensive lung transplant wait lists than Texas.
“The CMS certification makes our program more
accessible to people in Texas and around the country who need a lung transplant,”
said Soma Jyothula,
medical director of the Lung Transplant
Program at Memorial Hermann-TMC and assistant professor at McGovern
Medical School at UTHealth in the Center for Advanced Heart Failure. “We have
had great lung transplant patient outcomes and we are now able to better realize
our vision of improving quality of life for those with chronic lung disease.”
Government certification of transplant
programs requires transplant centers to undergo thorough evaluation of proven
ability to meet stringent standards for quality and patient outcomes. The
heart, kidney, liver and pancreas transplant programs at Memorial Hermann-TMC are
also CMS certified. The lung transplant program is the newest of the transplant
programs at Memorial Hermann-TMC.
UNOS approved Memorial Hermann-TMC’s
application to initiate a lung transplant program in the fall of 2015. The
center’s first lung transplant was performed in December 2015, after which the
process of obtaining CMS certification began. Since then, the program team
members have worked diligently toward certification, which is required before Medicare
and Medicaid enrollees can receive in-network coverage of a transplant
program’s services. Many private insurers also require CMS certification before
approving transplant services.
“The purposes of lung transplantation,
currently the sole treatment for end-stage lung disease, are improved patient
survival, improved functional capacity, and relief of symptoms,” said Keshava Rajagopal,
surgical director of the Lung Transplant Program at Memorial Hermann-TMC and
assistant professor at McGovern Medical School in the Center for Advanced Heart
Failure. “As our program expands, we will continue to focus on sustained high
quality and scientific and clinical innovation in end-stage lung disease.”
Numbers to know about the Lung Transplant
Program at Memorial Hermann-TMC:
95 percent: Survival outcomes
to date of nearly 95 percent, which is higher than the national averages for
all adult age groups for 1-, 3- and 5-year survival, according to UNOS data.
22.5 days: The median
wait-list time for candidates. 84 percent of current UNOS registrants have been
waiting for more than 30 days. Nearly two-thirds of those on the list in Texas
have been waiting more than 90 days.
17 days: Post-transplant,
the median length of stay. 84 percent of patients in the Lung Transplant
Program have been discharged from the hospital within 30 days.
65 years: More than 50
percent of its transplant recipients are aged 65 or older, who often have
greater health risks and complex lung illnesses, including: idiopathic
pulmonary fibrosis/interstitial lung disease, emphysema (chronic obstructive
pulmonary disease), pulmonary hypertension and sarcoidosis.
“Our patients with end-stage chronic lung
disease who are awaiting lung transplant are now assured an uninterrupted continuum
of care, from diagnosis to surgery, and throughout post-surgical and follow-up
care,” Dr. Jyothula said.
Transplant Program at Memorial Hermann-TMC is part of the Center for
Advanced Heart Failure at Memorial
Hermann Heart & Vascular Institute-TMC and
the Department of Advanced Cardiopulmonary Therapies and Transplantation at
McGovern Medical School.
Learn more about the Lung Transplant Program at Memorial
Hermann-TMC or call 713-222-2273.